HomeNewsBusinessReal Estate91% respondents prefer buying property over renting despite COVID-19 challenges: JLL survey

91% respondents prefer buying property over renting despite COVID-19 challenges: JLL survey

Potential buyers above 35 years indicated that they are more inclined towards buying a property in the next six months. Over half indicated a preference for a 2BHK apartment

July 29, 2020 / 15:47 IST
Story continues below Advertisement

Economic uncertainty and rising stock market volatility is positioning real estate as the preferred asset class for investments in India with over 91 percent preferring to buy an apartment over renting in the next six months, says JLL, a real estate consultancy firm.

According to JLL’s Homebuyer Preference Survey, 91 percent respondents wanted to buy a home when asked to choose between buying and renting. Additionally, 67 percent believed that buying a home is a necessity, not a luxury.

Story continues below Advertisement

The evolving COVID-19 pandemic will also influence short-term decision making with job security cited as the biggest concern when contemplating the purchase of a home, respondents said.

The survey uncovered that a greater proportion of people in the age group of 20-35 years were likely to defer their home purchase plans by more than six months. Polled consumers above 35 years indicated that they are more inclined towards buying a property in the next six months.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show